Bank of America’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bank of America's FLXN Position: Q4 2021 in Review

Bank of America sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 73,004 shares — an estimated $445K sold.

Bank of America first reported a position in FLXN in Q1 2014 and held it in 31 quarters. The position peaked at $8.47M in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

• Bank of America reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
• Bank of America sold 73,004 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $445K.
• Bank of America first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 31 quarters.
• Bank of America's Flexion Therapeutics, Inc. position peaked at $8.47M in Q2 2020.
• 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.